冠心病慢性心力衰竭患者尿中性粒细胞明胶酶相关脂质运载蛋白的水平及其临床意义

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (714 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the changes of urinary neutrophil gelatinase-associated lipid (NGAL) level and its clinical significance in chronic heart failure patients with coronary heart disease.Methods From September 2014 to April 2015,90 chronic heart failure patients with coronary heart disease were divided into 3 groups according to the NYHA cardioac functional classification,30 cases in classⅠgroup, 30 cases in class Ⅱ group, 30 cases in class Ⅲ-Ⅳgroup .And then 30 healthy subjects were recruited in control group. The level of urine NGAL, serum creatinine, N-terminal pro-B-type natriuretic peptide (NT-proBNP) were detected in 4 groups. The left ventricular end-diastolic dimension (LVEDD), left ventricular ejection fraction (LVEF) were measured. And then the changes and clinical significance of each index were analyzed.Results With the heart failure severity ,the level of uNGAL in healthy control group, class Ⅰ,Ⅱ and Ⅲ-Ⅳ group patients increased, and class Ⅲ-Ⅳ increased most significantly.Compared with the control group , the level of uNGAL in class Ⅱ group, which was significantly higher than in control group (P<0.05), but no significant difference in Scr,compared with the control group. Conclusions The changes of uNGAL in patients of CHF with coronary heart disease increased earlier than Scr, which suggests that uNGAL is a sensitive and reliable marker for early renal damage in patients of CHF with coronary heart disease.

Key words： neutrophil gelatinase-associated lipocalin heart failure renal function

Received: 23 March 2016

ZTFLH:

R541.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHOU Binwei
	ZHAO Jihong
	and LIU Xinlin

Cite this article:

ZHOU Binwei,ZHAO Jihong,and LIU Xinlin. Changes and clinical significance of urinary NGAL in chronic heart failure patients with coronary heart disease[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2016, 27(8): 771-773.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2016/V27/I8/771

[1]	刑作英,王永霞,朱明军.慢性心力衰竭流行病学研究现状及其病因[J].中华实用诊断与治疗杂志,2012,26(10):937-938.
[2]	Ronco C,McCullough P,Anker S D,et al. Cardio－renal syndromes:report from the consensus conference of the acute dialysis quality initiative[J]. Eur Heart J,2010,31( 6) :703－711.
[3]	Singer E,Marko L,Paragas N,et al. Neutrophil gelatinase-associated lipocalin:pathophysiology and clinical applications[J].Acta Physiol(Oxf),2013,207(4):663-672.
[4]	Mishra J,Dent C,Tarabishi R,et al. Neutrophil gelatinase-associated lipocalin(NGAL) as a biomarker for acute renal injury after cardiac surgery[J].Lancet,2005,365(9466):1231-1238.
[5]	中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊治和诊疗指南[J].中华心血管病杂志,2014,42(2):98-122.
[6]	李丽,谭华清,唐湘宇. 心肾综合征发病机制及诊治的最新进展[J].中国当代医药,2014,21(35):194-197.
[7]	Devarajan P. Emerging biomarkers of acute kidney injury[J]. Contrib Nephrol,2007,156:203-212.
[8]	Mitsnefes M M,Kathman T S,Mishra J,et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease[J].Pediatr Nephrol,2007,22(1):101-108.
[9]	许文淼,鄢盛恺.中性粒细胞明胶酶相关脂质运载蛋白-1种新的肾损伤标志物[J]. 临床检验杂志,2011,29(4):285-286.
[10]	Paragas N,Qiu A,Zhang Q,et al. The Ngal reporter mouse detects the response of the kidney to injury in real time [J]. Nat Med,2011,17(2):216-222.
[11]	Chowdhury P,Choudhary R,Maisel A. The appropriate use of biomarkers in heart failure[J]. Med Clin North Am,2012,96(5):901-913.
[12]	朱红,马丽娜,杨伟,等. 老年冠心病慢性心力衰竭患者血清 NGAL与NT-proBNP的水平及临床意义[J]. 中华全科医学,2015,13(4):523-525.